Vea Impex (I) Private Limited is an Indian pharmaceutical exporter established on June 17, 2019, in Mumbai, Maharashtra. The company is registered under the Corporate Identification Number (CIN) U51909MH2019PTC326863. It operates as a private limited company with an authorized and paid-up capital of ₹500,000. The registered office is located at Unit No.6 1-C, Ground Floor, Hitex Embroidery Estate Vardhman Compound, S.V. Road, Dahisar East, Mumbai, Maharashtra, 400068, India. The company is unlisted and has been active since its incorporation.
Vea Impex (I) Private Limited specializes in the export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company's product portfolio spans 14 products across three therapeutic categories: Advanced Oncology (60.0%), Antiviral & HIV Medications (25.9%), and Brand Names & OTC Products (14.1%). The top five products by export value are Darunavir ($59K), Daratumumab ($58K), Nivolumab ($28K), Cetuximab ($22K), and Vinorelbine ($13K), collectively accounting for 78.5% of the total export value.
